Embecta (EMBC) Gross Margin (2020 - 2026)

Embecta (EMBC) posted Gross Margin of 57.62% for Q1 2026, down 6.93% sequentially from 61.91% in Q4 2025, and down 574.0% YoY from 12.16% in Q1 2025.

Embecta (EMBC) Gross Margin (2020 - 2026) Analysis & Trends

Embecta has reported Gross Margin for 7 years, with the latest figure at 57.62% in Q1 2026.

Quarterly Gross Margin fell 574.0% year-over-year to 57.62% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 61.88% (down 158.0% YoY) and the FY2025 annual result came in at 62.64%, down 282.0% from the prior year.
Gross Margin retreated to 57.62% in Q1 2026 per EMBC's latest filing, from 61.91% in the prior quarter.
Over five years, Gross Margin peaked at 69.76% in Q2 2024 and troughed at 57.62% in Q1 2026.
A 5-year average of 64.89% and a median of 64.55% in 2024 frame the typical range for Gross Margin.
The widest YoY moves for Gross Margin: up 353 bps in 2024, down 705 bps in 2024.
Over 5 years, Gross Margin stood at 68.48% in 2022, then fell by 2 bps to 67.04% in 2023, then declined by 11 bps to 59.98% in 2024, then grew by 3 bps to 61.91% in 2025, then retreated by 7 bps to 57.62% in 2026.
According to Business Quant data, Gross Margin over the past three periods registered 57.62%, 61.91%, and 60.04% for Q1 2026, Q4 2025, and Q3 2025 respectively.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Gross Margin (Qtr)
1	Intuitive Surgical	132.71 Bn	127.50 Bn	1.96 Bn	67.78%
2	Becton Dickinson	51.57 Bn	50.71 Bn	2.32 Bn	46.46%
3	Alcon	35.52 Bn	34.17 Bn	1.68 Bn	59.33%
4	Resmed	33.28 Bn	31.81 Bn	861.22 Mn	58.84%
5	Medline	27.86 Bn	25.18 Bn	2.22 Bn	28.82%
6	West Pharmaceutical Services	25.15 Bn	24.71 Bn	329.20 Mn	37.74%
7	Solventum	15.31 Bn	14.91 Bn	1.29 Bn	58.22%
8	Cooper Companies	14.86 Bn	14.72 Bn	735.40 Mn	68.00%
9	Baxter International	13.63 Bn	11.48 Bn	1.03 Bn	34.86%
10	Embecta	319.59 Mn	101.39 Mn	153.30 Mn	56.42%

Download Data